Deignan Charles A. 4
4 · Clearside Biomedical, Inc. · Filed Dec 20, 2022
Insider Transaction Report
Form 4
Deignan Charles A.
Chief Financial Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2022-12-20−23,636→ 0 totalExercise: $0.40Exp: 2023-02-28→ Common Stock (23,636 underlying) - Exercise/Conversion
Common Stock
2022-12-20$0.40/sh+23,636$9,454→ 377,502 total
Footnotes (1)
- [F1]Fully vested and exercisable.